Bubs Australia Limited (ASX: BUB) has released its Investor Presentation where it reports an increase in gross revenue by more than 37% during 1H FY2020 ended 31 December 2019 with Bubs® Goat Infant Formula being the key driver of the result.
- Stronger forecasted demand for infant formula is anticipated in 2HFY2020 across all distribution Channels.
- New markets & new product launches scheduled to build on current foundations to drive incremental revenue streams.
At AEDT 1:20 PM, BUB shares are trading at $0.705, down 2.759% from its previous close.
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.